EUVIMEDEUVIMED entdecken
Crossref

Regio- and Stereoselective Synthesis of Anticancer Imidazo[1,2- a ]pyridine–chromones Assisted by Hydrogen Bonding

Ya-Nan An, Jia-Le Yang, Cheng Cheng, Yi-Jun Lu, Xin Li, De-Jia Yang, Ya-Qian Lu, Jie Lei iD

The Journal of Organic Chemistry · 2026

DOI: 10.1021/acs.joc.6c01049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Organic Chemistry, 2026. Verfasst von Ya-Nan An und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase M…. Hauptthemen laut MEDLINE: Pyridines, Antineoplastic Agents, Imidazoles, Chromones. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Chongqing University of Arts and Sciences, Natural Science Foundation of Chongqing Municipality, Chongqing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous 1,2- or 1,4-addition reactions of imidazo[1,2-a]pyridines across unsaturated C═N or C═C bonds have been extensively studied. Regioselective 1,4-conjugate addition with the aid of hydrogen bonding remains unexplored. Herein, a regioselective and stereoselective approach for the synthesis of imidazo[1,2-a]pyridine–chromones has been achieved for the first time. Control experiments reveal that intramolecular hydrogen bonding plays an important role in achieving high selectivity. This protocol features operational simplicity, readily available feedstocks, and excellent regioselectivities and stereoselectivities. Significantly, evaluation of the newly synthesized compounds identified 4ag and 4ah as promising anticancer agents, exhibiting potent activity against A549 (IC50 = 1.95 and 3.10 μM, respectively) and HCT116 (IC50 = 4.11 and 3.32 μM, respectively) cell lines. This work not only provides a novel perspective on hydrogen-bonding-controlled chemical transformations but also offers an efficient, sustainable synthetic strategy for accessing new imidazo[1,2-a]pyridine-based candidates for biological evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridinesAntineoplastic AgentsImidazolesChromonesHydrogen BondingHumansStereoisomerismDrug Screening Assays, AntitumorCell ProliferationMolecular StructureStructure-Activity Relationship

Substanzen

PyridinesAntineoplastic AgentsImidazolesChromonesimidazo(1,2-a)pyridine

Autor:innen und Institutionen

  • College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing University of Arts and Sci…

ORCID-Profile: Jie Lei

Förderung

  • Chongqing University of Arts and Sciences
  • Natural Science Foundation of Chongqing Municipality
  • Chongqing Municipal Education Commission
  • Natural Science Foundation Project of Yongchuan
  • Chongqing Talents Foundation Project

Zitieren

APA

An, Y. N., Yang, J. L., Cheng, C., Lu, Y. J., Li, X., Yang, D. J., Lu, Y. Q., & Lei, J. (2026). Regio- and Stereoselective Synthesis of Anticancer Imidazo[1,2- a ]pyridine–chromones Assisted by Hydrogen Bonding. The Journal of Organic Chemistry. https://doi.org/10.1021/acs.joc.6c01049

Vancouver

An YN, Yang JL, Cheng C, Lu YJ, Li X, Yang DJ, et al. Regio- and Stereoselective Synthesis of Anticancer Imidazo[1,2- a ]pyridine–chromones Assisted by Hydrogen Bonding. The Journal of Organic Chemistry. 2026. doi:10.1021/acs.joc.6c01049

BibTeX
@article{An2026,
  author = {An, Ya-Nan and Yang, Jia-Le and Cheng, Cheng and Lu, Yi-Jun and Li, Xin and Yang, De-Jia and Lu, Ya-Qian and Lei, Jie},
  title = {Regio- and Stereoselective Synthesis of Anticancer Imidazo[1,2- a ]pyridine–chromones Assisted by Hydrogen Bonding},
  journal = {The Journal of Organic Chemistry},
  year = {2026},
  doi = {10.1021/acs.joc.6c01049}
}
Kostenlos starten →